Zentalis Pharmaceuticals, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -245.74%
EBIT Margin -283.57%
EBITDA Margin -283.57%
Operating Margin -283.57%
Net Margin -246.00%
FCF Margin -253.74%
Efficiency
Assets Average 545.50M491.01M
Equity Average 435.71M387.29M
Invested Capital 434.02M437.39M337.19M
Asset Utilization Ratio 0.14
Leverage & Solvency
Equity Ratio 0.800.790.78
Valuation
Enterprise Value 2,109.48M2,319.15M1,106.53M561.01M-225.52M
Market Capitalization 2,109.48M2,319.15M1,149.38M1,043.82M126.39M
Return Ratios
Return on Sales -2.46%
Return on Capital Employed -0.63%-0.44%
Return on Invested Capital -0.69%
Return on Assets -0.51%-0.34%
Return on Equity -0.63%-0.43%